Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Antimicrob Agents Chemother ; 47(12): 3890-900, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14638499

ABSTRACT

Ten mutants of the yeast Saccharomyces cerevisiae resistant to the antimycotic terbinafine were isolated after chemical or UV mutagenesis. Molecular analysis of these mutants revealed single base pair exchanges in the ERG1 gene coding for squalene epoxidase, the target of terbinafine. The mutants did not show cross-resistance to any of the substrates of various pleiotropic drug resistance efflux pumps tested. The ERG1 mRNA levels in the mutants did not differ from those in the wild-type parent strains. Terbinafine resistance was transmitted with the mutated alleles in gene replacement experiments, proving that single amino acid substitutions in the Erg1 protein were sufficient to confer the resistance phenotype. The amino acid changes caused by the point mutations were clustered in two regions of the Erg1 protein. Seven mutants carried the amino acid substitutions F402L (one mutant), F420L (one mutant), and P430S (five mutants) in the C-terminal part of the protein; and three mutants carried an L251F exchange in the central part of the protein. Interestingly, all exchanges identified involved amino acids which are conserved in the squalene epoxidases of yeasts and mammals. Two mutations that were generated by PCR mutagenesis of the ERG1 gene and that conferred terbinafine resistance mapped in the same regions of the Erg1 protein, with one resulting in an L251F exchange and the other resulting in an F433S exchange. The results strongly indicate that these regions are responsible for the interaction of yeast squalene epoxidase with terbinafine.


Subject(s)
Antifungal Agents/pharmacology , Naphthalenes/pharmacology , Oxygenases/genetics , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Alleles , Amino Acid Sequence , Cloning, Molecular , DNA, Fungal/genetics , Drug Resistance, Fungal , Escherichia coli/genetics , Genetic Vectors , Molecular Sequence Data , Mutagenesis , Plasmids/genetics , Recombination, Genetic , Squalene Monooxygenase , Terbinafine
2.
Biochem Biophys Res Commun ; 309(3): 666-71, 2003 Sep 26.
Article in English | MEDLINE | ID: mdl-12963042

ABSTRACT

A terbinafine-resistant mutant of the yeast Saccharomyces cerevisiae with a complex pleiotropic phenotype (resistance to terbinafine and itraconazole, sensitivity to several antifungal compounds, respiration deficiency, and temperature sensitivity) has been isolated after chemical mutagenesis. Detailed analysis revealed that some of its traits (thermosensitive growth, sensitivity to the polyene antimycotic nystatin and to calcofluor white) are linked to alterations in the cell wall. A single C1288G base change in the ERG1 gene resulting in the substitution of proline by alanine at position 430 in the enzyme squalene epoxidase (Erg1p) was identified as the sole cause of terbinafine resistance. This novel mutation in the ERG1 gene confers only partial resistance of Erg1p to terbinafine, however, even the low level of resistance enables terbinafine-treated mutant cells to maintain adequate ergosterol levels over longer cultivation periods. Lack of interference of squalene accumulation with growth of terbinafine-treated mutant cells indicates that the antimycotic effect of terbinafine in S. cerevisiae may be linked primarily to ergosterol depletion.


Subject(s)
Antifungal Agents/pharmacology , Drug Resistance, Fungal/genetics , Genes, Fungal , Naphthalenes/pharmacology , Oxygenases/genetics , Saccharomyces cerevisiae/genetics , Cell Membrane Permeability , Clone Cells , Ergosterol/biosynthesis , Phenotype , Point Mutation , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/enzymology , Squalene Monooxygenase , Terbinafine
SELECTION OF CITATIONS
SEARCH DETAIL
...